Literature DB >> 14760417

EMSY, a BRCA-2 partner in crime.

David M Livingston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14760417     DOI： 10.1038/nm0204-127

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

Review 1.  Genetics of eosinophilic esophagitis.

Authors:  L C Kottyan; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2017-02-22       Impact factor: 7.313

2.  EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.

Authors:  Antonio Marzio; Emma Kurz; Jennifer M Sahni; Giuseppe Di Feo; Joseph Puccini; Shaowen Jiang; Carolina Alcantara Hirsch; Arnaldo A Arbini; Warren L Wu; Harvey I Pass; Dafna Bar-Sagi; Thales Papagiannakopoulos; Michele Pagano
Journal:  Cell       Date:  2021-12-27       Impact factor: 41.582

3.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

4.  Absence of allelic imbalance involving EMSY, CAPN5, and PAK1 genes in papillary thyroid carcinoma.

Authors:  M Hidalgo; M E Saez; F J Martinez-Tello; F J Moron; E Ferrero-Herrero; M Labalde-Martinez; D Rigopoulou; C Ballestin-Carcavilla; A Ruiz; J L Royo; R Ramirez-Lorca
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

5.  Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

Authors:  Patrick R Benusiglio; Fabienne Lesueur; Craig Luccarini; Joan McIntosh; Robert N Luben; Paula Smith; Alison Dunning; Douglas F Easton; Bruce A J Ponder; Paul D Pharoah
Journal:  BMC Cancer       Date:  2005-07-19       Impact factor: 4.430

6.  Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

Authors:  Agnieszka Dansonka-Mieszkowska; Lukasz M Szafron; Joanna Moes-Sosnowska; Mariusz Kulinczak; Anna Balcerak; Bozena Konopka; Magdalena Kulesza; Agnieszka Budzilowska; Martyna Lukasik; Urszula Piekarska; Iwona K Rzepecka; Joanna Parada; Renata Zub; Barbara Pienkowska-Grela; Radoslaw Madry; Jan K Siwicki; Jolanta Kupryjanczyk
Journal:  Oncotarget       Date:  2018-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.